How can patients check Lumakras tablets price in India?

Lumakras (sotorasib) is an oral precision therapy developed for KRAS G12C-mutated cancers, especially advanced non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC). Many patients search for Lumakras tablets price in India because this innovative therapy is not yet locally marketed. The recommended dosage is 960 mg orally once daily. For NSCLC, it is prescribed as a single agent, while for mCRC, it is combined with panitumumab. Tablets must be swallowed whole, taken with or without meals. Though Lumakras is not commercially available in India, patients may obtain it under the Named Patient Program (NPP), a legal provision that allows import of unapproved but essential medicines for personal use. To request information about Lumakras tablets pricing and access, please reach us at +91 93100 90915 or dial our TOLL-FREE: 1800-889-1064.